KYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive Method
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 05 Feb 2019
At a glance
- Drugs Levonorgestrel (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Acronyms KYSS
- Sponsors Bayer
- 28 Jan 2019 Status changed from recruiting to active, no longer recruiting.
- 29 Oct 2018 Planned End Date changed from 29 Nov 2019 to 30 Mar 2020.
- 29 Oct 2018 Planned primary completion date changed from 31 Aug 2019 to 31 Dec 2019.